HUM analyst estimates
Humana (HUM) analyst ratings, the average price target and its range, and every firm's latest call.
HUM analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 13, 2026 | Mizuho Securities | Humana price target raised to $495 from $468 at Mizuho | $495.00 |
| Oct 12, 2026 | Raymond James | Humana upgraded to Outperform from Market Perform at Raymond James | $520.00 |
| Oct 12, 2026 | Truist Financial | Humana price target raised to $475 from $415 at Truist | $475.00 |
| Oct 12, 2026 | UBS | Humana price target raised to $495 from $405 at UBS | $495.00 |
| Oct 12, 2026 | Oppenheimer | Humana price target raised to $525 from $475 at Oppenheimer | $525.00 |
| Oct 9, 2026 | Robert W. Baird | Baird Upgrades Humana (HUM) to Outperform | $596.00 |
| Oct 9, 2026 | UBS | Humana upgraded to Outperform from Neutral at Baird | $596.00 |
| Oct 9, 2026 | Barclays | Humana price target raised to $582 from $515 at Barclays | $582.00 |
| Oct 9, 2026 | Oppenheimer | Humana price target raised to $475 from $405 at Oppenheimer | $475.00 |
| Oct 7, 2026 | Raymond James | Humana upgraded to Overweight from Neutral at Cantor Fitzgerald | $460.00 |
| Sep 25, 2026 | Barclays | Humana upgraded to Overweight from Equal Weight at Barclays | $515.00 |
| Aug 24, 2026 | Wolfe Research | Humana (HUM) PT Raised to $450 at Wolfe Research | $450.00 |
| Aug 4, 2026 | Morgan Stanley | Humana upgraded to Equal Weight from Underweight at Morgan Stanley | $370.00 |
| Jul 31, 2026 | Barclays | Humana price target raised to $407 from $344 at Barclays | $407.00 |
| Jul 30, 2026 | Piper Sandler | Piper upgrades Humana to Overweight on enterprise earnings growth | $463.00 |
- 20 firms rate HUM: 11 buy, 8 hold, 1 sell.
- The average price target is $497.10 from 10 analysts, from $370.00 to $596.00.
Updated 2026-11-02 17:53 UTC